Breo ellipta and Rocephin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Breo ellipta (fluticasone furoate; vilanterol trifenatate) and Rocephin (ceftriaxone sodium). Common drug interactions include acute respiratory failure among females and anxiety among males.
The phase IV clinical study analyzes what interactions people have when they take Breo ellipta and Rocephin. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.
What is Breo ellipta?
Breo ellipta has active ingredients of fluticasone furoate; vilanterol trifenatate. It is often used in asthma. eHealthMe is studying from 37,362 Breo ellipta users. Check the latest studies of Breo ellipta.
What is Rocephin?
Rocephin has active ingredients of ceftriaxone sodium. It is often used in infection. eHealthMe is studying from 15,665 Rocephin users. Check the latest studies of Rocephin.
21 people who take Breo ellipta and Rocephin together, and have interactions are studied.

What are the common drug interactions of Breo Ellipta and Rocephin, by gender? *:
female:
- Acute respiratory failure
- Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)
- Cellulitis (infection under the skin)
- Corona virus infection (infection caused by a corona virus)
- Dyspnoea (difficult or laboured respiration)
- Hypokalaemia (low potassium)
- Productive cough
- Rhinovirus infection
- Sputum discoloured
- Wheezing (a high-pitched whistling sound made while you breath)
male:
- Anxiety
- Chronic kidney disease
- Muscular weakness (muscle weakness)
- Depression
- Gout (uric acid crystals building up in the body)
- Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
- Panic attack
- Renal failure (kidney dysfunction)
- Renal impairment (severely reduced kidney function)
- Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
What are the common drug interactions of Breo Ellipta and Rocephin, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Device failure
- Drug ineffective
- Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
30-39:
n/a
40-49:
- Anxiety
- Chronic kidney disease
- Depression
- Gout (uric acid crystals building up in the body)
- Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
- Panic attack
- Renal failure (kidney dysfunction)
- Renal impairment (severely reduced kidney function)
- Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
- Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
50-59:
- Acute respiratory failure
- Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)
- Cellulitis (infection under the skin)
- Corona virus infection (infection caused by a corona virus)
- Dyspnoea (difficult or laboured respiration)
- Hypokalaemia (low potassium)
- Productive cough
- Rhinovirus infection
- Sputum discoloured
- Wheezing (a high-pitched whistling sound made while you breath)
60+:
- Chronic kidney disease
- Nephrogenic anaemia (anaemia due to kidney disease)
- Muscular weakness (muscle weakness)
- Nephrotic syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema)
- Renal injury (kidney injury)
- Renal tubular necrosis (death of kidney tubules)
- Renal failure (kidney dysfunction)
- Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
What are the existing conditions these people have? *
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 38.10%
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 6 people, 28.57%
- Pain: 5 people, 23.81%
- Insomnia (sleeplessness): 5 people, 23.81%
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 4 people, 19.05%
- High Blood Pressure: 3 people, 14.29%
- High Blood Cholesterol: 3 people, 14.29%
- Vitamin B12 Deficiency: 2 people, 9.52%
- Headache (pain in head): 2 people, 9.52%
- Blood Pressure Abnormal: 2 people, 9.52%
* Approximation only. Some reports may have incomplete information.
Do you take Breo ellipta and Rocephin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Breo ellipta (37,362 reports)
- Rocephin (15,665 reports)
Browse all drug interactions of Breo ellipta and Rocephin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Breo ellipta:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Rocephin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Breo ellipta and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Rocephin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Agrawal SR, Rajput A, Jain AP, "Leukocytoclastic vasculitis and acute allergic interstitial nephritis following ceftriaxone exposure", Journal of pharmacology & pharmacotherapeutics, 2014 Jan .
- Agrawal SR, Rajput A, Jain AP, "Leukocytoclastic vasculitis and acute allergic interstitial nephritis following ceftriaxone exposure", Journal of pharmacology & pharmacotherapeutics, 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on fluticasone furoate; vilanterol trifenatate and ceftriaxone sodium (the active ingredients of Breo ellipta and Rocephin, respectively), and Breo ellipta and Rocephin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Atrovent cause Squamous Cell Carcinoma? - now
- Actonel and Angina Pectoris Aggravated for Men aged 60+ - a second ago
- Drug interactions of Irbesartan and Bosulif - 3 seconds ago
- Gaze Palsy and drugs of ingredients of amantadine hydrochloride - 10 seconds ago
- Hemiparesis and drugs of ingredients of fondaparinux sodium - 13 seconds ago
- Could Kimmtrak cause Rashes? - 21 seconds ago
- Drug interactions of Magnesium Aspartate and Olanzapine - 28 seconds ago
- Could Methotrexate Sodium cause Diabetes Mellitus Inadequate Control? - 29 seconds ago
- Fatigue in Cyclosporine, how severe and when it was recovered? - 46 seconds ago
- Smoke Sensitivity and drugs of ingredients of ciclesonide - 47 seconds ago